DocuSign, Inc. (NASDAQ:DOCU – Get Free Report) Director Teresa Briggs sold 534 shares of the firm’s stock in a transaction on Monday, March 17th. The shares were sold at an average price of $87.41, for a total value of $46,676.94. Following the completion of the sale, the director now directly owns 8,270 shares of the company’s stock, valued at approximately $722,880.70. This trade represents a 6.07 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this link.
DocuSign Price Performance
NASDAQ:DOCU opened at $83.43 on Tuesday. The firm has a market cap of $16.85 billion, a PE ratio of 17.20, a P/E/G ratio of 6.94 and a beta of 1.02. The firm has a 50 day simple moving average of $87.82 and a 200-day simple moving average of $79.69. DocuSign, Inc. has a 1-year low of $48.70 and a 1-year high of $107.86.
DocuSign (NASDAQ:DOCU – Get Free Report) last issued its quarterly earnings results on Thursday, March 13th. The company reported $0.86 earnings per share for the quarter, beating the consensus estimate of $0.84 by $0.02. The company had revenue of $776.25 million during the quarter, compared to the consensus estimate of $760.94 million. DocuSign had a return on equity of 14.90% and a net margin of 34.73%. DocuSign’s revenue was up 9.0% on a year-over-year basis. During the same period in the previous year, the firm posted $0.76 EPS. As a group, sell-side analysts expect that DocuSign, Inc. will post 1.17 earnings per share for the current fiscal year.
Institutional Trading of DocuSign
Wall Street Analysts Forecast Growth
DOCU has been the subject of several recent analyst reports. Bank of America reduced their price objective on shares of DocuSign from $112.00 to $98.00 and set a “neutral” rating for the company in a research note on Friday. Needham & Company LLC restated a “hold” rating on shares of DocuSign in a report on Friday. Robert W. Baird lifted their price objective on DocuSign from $59.00 to $100.00 and gave the stock a “neutral” rating in a report on Friday, December 6th. Wedbush reiterated a “neutral” rating and set a $100.00 target price on shares of DocuSign in a research report on Friday. Finally, JMP Securities restated a “market outperform” rating and issued a $124.00 price target on shares of DocuSign in a research report on Tuesday, January 7th. Two research analysts have rated the stock with a sell rating, nine have given a hold rating and four have given a buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Hold” and an average target price of $95.58.
Check Out Our Latest Stock Report on DOCU
About DocuSign
DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.
Recommended Stories
- Five stocks we like better than DocuSign
- What Are Growth Stocks and Investing in Them
- Can TikTok Stock Picks Really Make You Rich?
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- The “Quality” Rotation: Back to Basics Investing
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- Occidental Petroleum: 4 Reasons to Love These Prices
Receive News & Ratings for DocuSign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocuSign and related companies with MarketBeat.com's FREE daily email newsletter.